These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17530012)

  • 21. Idiotypic network and tumor therapy. Proceedings of the First International Meeting of Immunological Approaches to Tumor Therapy by Antibodies and Tumor Cell Vaccines. Bonn, February 6, 1993.
    Hybridoma; 1993 Oct; 12(5):493-630. PubMed ID: 8300121
    [No Abstract]   [Full Text] [Related]  

  • 22. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective iodination and cytotoxicity of tumor cells with an antibody-enzyme conjugate.
    Philpott GW; Bower RJ; Parker CW
    Surgery; 1973 Jul; 74(1):51-8. PubMed ID: 4715882
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeted immunotherapy of cancer: development of antibody-induced cellular immunity.
    Lu Y; Low PS
    J Pharm Pharmacol; 2003 Feb; 55(2):163-7. PubMed ID: 12635651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspective.
    Desjarlais JR; Lazar GA; Zhukovsky EA; Chu SY
    Drug Discov Today; 2007 Nov; 12(21-22):898-910. PubMed ID: 17993407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytophilic antibody and cancer therapy: review and postulate.
    Berken A
    N Y State J Med; 1979 May; 79(6):849-52. PubMed ID: 286183
    [No Abstract]   [Full Text] [Related]  

  • 28. Bi-specific antibodies in cancer therapy.
    Wang H; Liu Y; Wei L; Guo Y
    Adv Exp Med Biol; 2000; 465():369-80. PubMed ID: 10810641
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunotherapy of cancer].
    Rümke P
    Tijdschr Ziekenverpl; 1976 Jan; 29(1):15-22. PubMed ID: 1043534
    [No Abstract]   [Full Text] [Related]  

  • 30. Technological advances in radioimmunotherapy.
    Dearling JL; Pedley RB
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):457-69. PubMed ID: 17537620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody carriers of drugs and toxins in tumor therapy.
    Immunol Rev; 1982; 62():1-216. PubMed ID: 7076274
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeting of monoclonal antibodies to tumours.
    Courtenay-Luck NS; Epenetos AA
    Curr Opin Immunol; 1989-1990; 2(6):880-3. PubMed ID: 2486568
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International symposium on labeled and unlabeled antibody cancer diagnosis and therapy. Baltimore, Maryland, September 12-13, 1985. Proceedings.
    NCI Monogr; 1987; (3):1-167. PubMed ID: 3821909
    [No Abstract]   [Full Text] [Related]  

  • 35. [Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens].
    Shebzukhov IuV; Belousov PV; Khlgatian SV; Sazykin AIu; Kuprash DV; Nedospasov SA
    Mol Gen Mikrobiol Virusol; 2007; (2):3-6. PubMed ID: 17600920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models.
    Kim S; Fridlender ZG; Dunn R; Kehry MR; Kapoor V; Blouin A; Kaiser LR; Albelda SM
    J Immunother; 2008 Jun; 31(5):446-57. PubMed ID: 18463540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sendai virus for cancer immunotherapy.
    Ueda Y; Hasegawa M; Yonemitsu Y
    Methods Mol Biol; 2009; 515():299-308. PubMed ID: 19378123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering therapeutic monoclonal antibodies.
    Liu XY; Pop LM; Vitetta ES
    Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis.
    Okamoto OK; Perez JF
    Expert Rev Mol Diagn; 2008 Jul; 8(4):387-93. PubMed ID: 18598221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.